Effect of 5-azacytidine on the protein expression of porcine bone marrow mesenchymal stem cells in vitro

Genomics, Proteomics and Bioinformatics

Volumn 4, Issue 1, 2006, Pages 18-25

  Ye, Neng Sheng ^a   Zhang, Rong Li ^a   Zhao, Yan Feng ^a   Feng, Xue ^a   Wang, Yi Ming ^a   Luo, Guo An ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

5 azacytidine; Bone marrow mesenchymal stem cells; Mass spectrometry; Proteome; Two dimensional gel electrophoresis

Indexed keywords

ALPHA CRYSTALLIN; AZACITIDINE; CELL PROTEIN; LIPOCORTIN 2; PROTEOME; STATHMIN; STATHMIN 1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSPLANTATION; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MESENCHYMAL STEM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PLURIPOTENT STEM CELL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; SIGNAL TRANSDUCTION; SWINE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALIA; SUIDAE; SUS SCROFA;

EID: 33645716751     PISSN: 16720229     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1672-0229(06)60012-0     Document Type: Article

References (43)

1. Jiang, Y., et al. 2002. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418: 41-49.
2. Deans, R.J. and Moseley, A.B. 2000. Mesenchymal stem cells: biology and potential clinical uses. Exp. Hematol. 28: 875-884.
3. Wakitani, S., et al. 1995. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18: 1417-1426.
4. Fukuda, K. 2002. Reprogramming of bone marrow mesenchymal stem cells into cardiomyocytes. C. R. Biol. 325: 1027-1038.
5. Tomita, S., et al. 1999. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100: 11247-256.
6. Tomita, S., et al. 2002. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J. Thorac. Cardiovasc. Surg. 123: 1132-1140.
7. Strauer, B.E., et al. 2002. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106: 1913-1918.
8. Edge, A.S., et al. 1998. Xenogeneic cell therapy: current progress and future developments in porcine cell transplantation. Cell Transplant. 7: 525-539.
9. Fang, L.J., et al. 2003. Isolation and culture of multipotent mesenchymal stem cells from porcine bone marrow. Chin. Crit. Care Med. 15: 606-608.
10. Moscoso, I., et al. 2005. Differentiation "in vitro" of primary and immortalized porcine mesenchymal stem cells into cardiomyocytes for cell transplantation. Transplant Proc. 37: 481-482.
11. Shake, J.G., et al. 2002. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann. Thorac. Surg. 73: 1919-1925.
12. Tomita, S., et al. 2002. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J. Thorac. Cardiovasc. Surg. 123: 1132-1140.
13. Rassi, C.M., et al. 2005. Modulation of osteoclasto-genesis in porcine bone marrow cultures by quercetin and rutin. Cell Tissue Res. 319: 383-393.
14. Ringe, J., et al. 2002. Porcine mesenchymal stem cells. Induction of distinct mesenchymal cell lineages. Cell Tissue Res. 307: 321-327.
15. Liu, Y., et al. 2003. Growth and differentiation of rat bone marrow stromal cells: does 5-azacytidine trigger their cardiomyogenic differentiation? Cardiovasc. Res. 58: 460-468.
16. Turck, N., et al. 2004. Proteomic analysis of nuclear proteins from proliferative and differentiated human colonic intestinal epithelial cells. Proteomics 4: 93-105.
17. Zhang, G., et al. 2004. Applying proteomic methodologies to analyze the effect of hexamethylene bisacetamide (HMBA) on proliferation and differentiation of human gastric carcinoma BGC-823 cells. Int. J. Biochem. Cell Biol. 36: 1613-1623.
18. Unwin, R.D., et al. 2003. The potential for proteomic definition of stem cell populations. Exp. Hematol. 31: 1147-1159.
19. Guo, X., et al. 2001. Proteomic characterization of early-stage differentiation of mouse embryonic stem cells into neural cells induced by all-trans retinoic acid in vitro. Electrophoresis 22: 3067-3075.
20. Hayman, M.W. and Przyborski, S.A. 2004. Proteomic identification of biomarkers expressed by human pluripotent stem cells. Biochem. Biophys. Res. Commun. 316: 918-923.
21. Maurer, M.H., et al. 2004. Comprehensive proteome expression profiling of undifferentiated versus differentiated neural stem cells from adult rat hippocampus. Neurochem. Res. 29: 1129-1144.
22. Barry, F., et al. 2001. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components. Exp. Cell Res. 268: 189-200.
23. Silva, W.A. Jr., et al. 2003. The profile of gene expression of human marrow mesenchymal stem cells. Stem Cells 21: 661-669.
24. Panepucci, R.A., et al. 2004. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells 22: 1263-1278.
25. Hishikawa, K., et al. 2004. Gene expression profile of human mesenchymal stem cells during osteogenesis in three-dimensional thermoreversible gelation polymer. Biochem. Biophys. Res. Commun. 317: 1103-1107.
26. Wang, D., et al. 2004. Proteomic profiling of bone marrow mesenchymal stem cells upon transforming growth factor beta1 stimulation. J. Biol. Chem. 279: 43725-43734.
27. Kratchmarova, I., et al. 2005. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 308: 1472-1477.
28. Liang, P., and MacRae, T.H. 1997. Molecular chaperones and the cytoskeleton. J. Cell Sci. 110: 1431-1440.
29. Guay, J., et al. 1997. Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27. J. Cell Sci. 110: 357-368.
30. Mehlen, P., et al. 1997. HSP27 as a switch between differentiation and apoptosis in murine embryonic stem cells. J. Biol. Chem. 272: 31657-31665.
31. Gilmore, W.S., et al. 2004. Annexin A2 expression during cellular differentiation in myeloid cell lines. Biochem. Soc. Trans. 32: 1122-1123.
32. Prosperi, M.T., et al. 1993. A human cDNA corresponding to a gene overexpressed during cell proliferation encodes a product sharing homology with amoebic and bacterial proteins. J. Biol. Chem. 268: 11050-11056.
33. Lim, M.J., et al. 1998. The type II peroxiredoxin gene family of the mouse: molecular structure, expression and evolution. Gene 216: 197-205.
34. Kim, W. and Kang, K. 2002. Recent developments of cathepsin inhibitors and their selectivity. Expert Opin. Ther. Patents 12: 419-432.
35. Kaplan, D.D., et al. 2004. Identification of a role for beta-catenin in the establishment of a bipolar mitotic spindle. J. Biol. Chem. 279: 10829-10832.
36. Mbalaviele, G., et al. 2005. Beta-catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation. J. Cell. Biochem. 94: 403-418.
37. Hurlstone, A.F., et al. 2003. The Wnt/beta-catenin pathway regulates cardiac valve formation. Nature 425: 633-637.
38. Nakamura, T., et al. 2003. A Wnt- and beta-catenin-dependent pathway for mammalian cardiac myogenesis. Proc. Natl. Acad. Sci. USA 100: 5834-5839.
39. Cornet, F., et al. 2004. Effect of dexamethasone on moesin gene expression in rabbit bone marrow stromal cells. Mol. Cell. Biochem. 265: 79-83.
40. Melhem, R.F., et al. 1991. Involvement of OP18 in cell proliferation. Biochem. Biophys. Res. Commun. 179: 1649-1655.
41. Di Paolo, G., et al. 1996. The phosphoprotein stathmin is essential for nerve growth factor-stimulated differentiation. J. Cell Biol 133: 1383-1390.
42. Chang, C.L., et al. 2001. Oncoprotein 18 levels and phosphorylation mediate megakaryocyte polyploidization in human erythroleukemia cells. Proteomics 1: 1415-1423.
43. Rubin, C.I., et al. 2003. Stathmin expression and megakaryocyte differentiation: a potential role in polyploidy. Exp. Hematol 31: 389-397.